Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | pyruvate kinase, putative | 0.014 | 0.3303 | 0.8567 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.014 | 0.3303 | 1 |
Echinococcus multilocularis | GA binding protein alpha chain | 0.0073 | 0.1038 | 0.0044 |
Loa Loa (eye worm) | hypothetical protein | 0.0097 | 0.187 | 0.192 |
Brugia malayi | Fli-1 protein | 0.0221 | 0.6068 | 0.6952 |
Loa Loa (eye worm) | pyruvate kinase | 0.014 | 0.3303 | 0.3609 |
Loa Loa (eye worm) | pyruvate kinase | 0.014 | 0.3303 | 0.3609 |
Schistosoma mansoni | hypothetical protein | 0.0189 | 0.4975 | 0.5579 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0088 | 0.1555 | 0.0619 |
Brugia malayi | Ets-domain containing protein | 0.0073 | 0.1038 | 0.1189 |
Echinococcus granulosus | geminin | 0.0189 | 0.4975 | 0.4418 |
Loa Loa (eye worm) | pyruvate kinase | 0.014 | 0.3303 | 0.3609 |
Echinococcus multilocularis | pyruvate kinase | 0.014 | 0.3303 | 0.2561 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.014 | 0.3303 | 0.8567 |
Echinococcus multilocularis | pyruvate kinase | 0.014 | 0.3303 | 0.2561 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.014 | 0.3303 | 0.5 |
Mycobacterium ulcerans | adenosylmethionine-8-amino-7-oxononanoate aminotransferase | 0.0148 | 0.3596 | 1 |
Echinococcus granulosus | pyruvate kinase | 0.014 | 0.3303 | 0.2561 |
Echinococcus multilocularis | pyruvate kinase | 0.011 | 0.2305 | 0.1452 |
Loa Loa (eye worm) | fli-1 protein | 0.0221 | 0.6068 | 0.6866 |
Schistosoma mansoni | gabp alpha | 0.0073 | 0.1038 | 0.0939 |
Plasmodium vivax | pyruvate kinase, putative | 0.014 | 0.3303 | 1 |
Mycobacterium tuberculosis | Probable aminotransferase | 0.0148 | 0.3596 | 1 |
Echinococcus multilocularis | tumor protein p63 | 0.0337 | 1 | 1 |
Entamoeba histolytica | pyruvate kinase, putative | 0.0097 | 0.187 | 1 |
Loa Loa (eye worm) | pyruvate kinase-PB | 0.0097 | 0.187 | 0.192 |
Leishmania major | pyruvate kinase | 0.014 | 0.3303 | 0.5 |
Loa Loa (eye worm) | D-ets-4 DNA binding domain-containing protein | 0.0073 | 0.1038 | 0.0939 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0088 | 0.1555 | 0.2417 |
Schistosoma mansoni | pyruvate kinase | 0.014 | 0.3303 | 0.3609 |
Mycobacterium leprae | PROBABLE ADENOSYLMETHIONINE-8-AMINO-7-OXONONANOATE AMINOTRANSFERASE BIOA | 0.0148 | 0.3596 | 1 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.03 | 0.8728 | 0.8587 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 0.0679 | 0.0517 |
Schistosoma mansoni | ets-related | 0.0221 | 0.6068 | 0.6866 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0088 | 0.1555 | 0.2417 |
Loa Loa (eye worm) | acetyltransferase | 0.03 | 0.8728 | 1 |
Chlamydia trachomatis | pyruvate kinase | 0.014 | 0.3303 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0148 | 0.3596 | 1 |
Echinococcus granulosus | pyruvate kinase | 0.014 | 0.3303 | 0.2561 |
Echinococcus granulosus | GA binding protein alpha chain | 0.0073 | 0.1038 | 0.0044 |
Loa Loa (eye worm) | hypothetical protein | 0.014 | 0.3303 | 0.3609 |
Trichomonas vaginalis | acetylornithine aminotransferase, putative | 0.0148 | 0.3596 | 1 |
Schistosoma mansoni | pyruvate kinase | 0.0072 | 0.0998 | 0.0893 |
Schistosoma mansoni | pyruvate kinase | 0.014 | 0.3303 | 0.3609 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.0081 | 0.1306 | 0.1337 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.03 | 0.8728 | 1 |
Brugia malayi | Ets-domain containing protein | 0.0073 | 0.1038 | 0.1189 |
Brugia malayi | Pyruvate kinase, muscle isozyme | 0.014 | 0.3303 | 0.3785 |
Leishmania major | pyruvate kinase | 0.014 | 0.3303 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0189 | 0.4975 | 0.5579 |
Giardia lamblia | Pyruvate kinase | 0.014 | 0.3303 | 1 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.014 | 0.3303 | 1 |
Echinococcus multilocularis | geminin | 0.0189 | 0.4975 | 0.4418 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0081 | 0.1306 | 0.1337 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0291 | 0.8443 | 0.8271 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.014 | 0.3303 | 1 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0088 | 0.1555 | 0.2417 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.03 | 0.8728 | 1 |
Mycobacterium tuberculosis | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | 0.0148 | 0.3596 | 1 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.014 | 0.3303 | 0.5 |
Toxoplasma gondii | pyruvate kinase PyK1 | 0.014 | 0.3303 | 1 |
Plasmodium falciparum | pyruvate kinase | 0.014 | 0.3303 | 1 |
Trypanosoma brucei | pyruvate kinase 1, putative | 0.014 | 0.3303 | 0.5 |
Trypanosoma brucei | pyruvate kinase 1 | 0.014 | 0.3303 | 0.5 |
Brugia malayi | Pyruvate kinase, M2 isozyme | 0.014 | 0.3303 | 0.3785 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.